BioSpace News Archive

Cidara Therapeutics, Inc. announced that the Compensation Committee of its Board of Directors granted non-qualified stock option awards and restricted stock units for an aggregate of 172,000 shares of its common stock to eight new employees, pursuant to the Cidara Therapeutics, Inc.

Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it has signed an exclusive worldwide licensing agreement with Altesa Biosciences, Inc. to allow Altesa to develop and commercialize Vaxart’s patented formulation of the capsid-binding VapendavirTM, a clinical-stage broad spectrum antiviral.

MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the appointment of Tina C. Beamon, J.D., as chief compliance officer, effective immediately

Trial will be conducted at the Israeli Medical Center for Alzheimer’s and will evaluate the safety, tolerability and efficacy of SCI-110

Thermo Fisher Scientific, (NYSE: TMO) the world leader in serving science, and the University of California, Davis (UC Davis) West Coast Metabolomics Center today announced The Center of Excellence in Clinical Metabolomics, a research collaboration to provide the metabolomics community with innovations, best practices and standard operating procedures to support the rapid scale-up of large cohort studies and clinical research

Zeta Surgical, a Y Combinator-backed surgical robotics company, announced that it has entered into an exclusive licensing agreement with Brigham and Women’s Hospital.

Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced the publication of an analysis highlighting that Bladder EpiCheck® can reduce both patient burden and healthcare system costs in the U.S. and European countries for low grade intermediate risk non-muscle invasive bladder cancer (NMIBC)

Biotricity, Inc. today announced preliminary revenue results guidance for its 2022 fiscal first quarter, ended June 30, 2021.

VBI Vaccines Inc. today announced that Linda Bain, Chief Financial Officer of Codiak BioSciences, Inc., has joined its Board of Directors.

Today at the American Orthopaedic Society for Sports Medicine annual meeting, Marrow Access Technologies announced full US market release of the SmartShot Marrow Access Device.